Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy.

Effective treatment of tuberculosis requires adherence to a minimum of 6 months treatment with multiple drugs. To improve adherence and cure rates, directly observed therapy is recommended for the treatment of pulmonary tuberculosis. We compared treatment outcomes among all culture-positive patients treated for active pulmonary tuberculosis (n = 372) in San Francisco County, California from 1998 through 2000. Patients treated by directly observed therapy at the start of therapy (n = 149) had a significantly higher cure rate compared with patients treated by self-administered therapy (n = 223) (the sum of bacteriologic cure and completion of treatment, 97.8% versus 88.6%, p < 0.002), and decreased tuberculosis-related mortality (0% vs. 5.5%, p = 0.002). Rates of treatment failure, relapse, and acquired drug resistance were similar between the two groups. Forty-four percent of patients who received self-administered therapy had risk factors for nonadherence and should have been assigned to directly observed therapy. We conclude that treatment plans that emphasize directly observed therapy from the start of therapy have the greatest success in improving tuberculosis treatment outcomes.

[1]  W. Sibbald,et al.  Critical oxygen delivery in conscious septic rats under stagnant or anemic hypoxia. , 2003, American journal of respiratory and critical care medicine.

[2]  Charles L Daley,et al.  American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. , 2003, American journal of respiratory and critical care medicine.

[3]  R. Chaisson,et al.  Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial , 2002, The Lancet.

[4]  J Li,et al.  Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. Walley,et al.  Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan , 2001, The Lancet.

[6]  M. Zwarenstein,et al.  A randomised controlled trial of lay health workers as direct observers for treatment of tuberculosis. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[7]  H Sawert,et al.  Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[8]  Merrick Zwarenstein,et al.  Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis , 1998, The Lancet.

[9]  V A Kazandjian,et al.  Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel. , 1998, JAMA.

[10]  R. Reves,et al.  Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. , 1997, Chest.

[11]  R. Chaisson,et al.  Eleven years of community-based directly observed therapy for tuberculosis. , 1995, JAMA.

[12]  R. Chaisson,et al.  Effectiveness of supervised, intermittent therapy for tuberculosis in HIV‐infected patients , 1994, AIDS.

[13]  D. Snider,et al.  Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. , 1994, American journal of respiratory and critical care medicine.

[14]  S. Weis,et al.  The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. , 1994, The New England journal of medicine.

[15]  D. Mitchison.  Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months. , 1993, The American review of respiratory disease.

[16]  D. Snider,et al.  Short-course (6-month) cooperative tuberculosis study in Poland: results 30 months after completion of treatment. , 1980, The American review of respiratory disease.

[17]  A. Nunn,et al.  [Short term chemotherapy of tuberculosis. Factors affecting relapse following short term chemotherapy]. , 1978, Bulletin of the International Union against Tuberculosis.

[18]  H. Rée.  Treatment of tuberculosis: Guidelines for national programmes (2nd edition): D. Maher, P. Chaulet, S. Spinaci & A. Harries (writing committee). Geneva: World Health Organization, 1997. 78pp. Price £7.50. WHO/TB/97.220 , 1999 .

[19]  Anthony D. Harries,et al.  Treatment of tuberculosis: guidelines for national programmes. Second edition. , 1997 .